Race against time: new stroke drug dose tested to save brain function
NCT ID NCT00147316
Summary
This study tested a lower dose of a clot-dissolving drug called alteplase for Japanese patients who had a stroke caused by a blocked blood vessel in the brain. The goal was to see if this lower dose could safely help patients recover more function after their stroke. The drug had to be given within 3 hours of the stroke starting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cardiovascular Center
Suita, Osaka, 565-8565, Japan
Conditions
Explore the condition pages connected to this study.